Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period

Completed

• Conditions: Covid-19

• Registration Number: NCT04415359
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

Because of the physiological changes inherent in pregnancy, pregnant women with lower respiratory tract infections often have more worrisome outcomes compared to non-pregnant individuals, including a higher rate of hospital and intensive care unit admissions.

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-05
• Study First Submitted: 2020-05-29
• Study First Submitted QC: 2020-05-29
• Study First Posted: 2020-06-04
• Study Start: 2020-08-01
• Primary Completion: 2020-10-31
• Study Completion: 2020-12-31
• Last Update Submitted: 2021-03-30
• Last Update Posted: 2021-04-01

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 700

Inclusion Criteria

• Patient included in a Medically Assisted Procreation (MAR) protocol aged between 18 and 43 years of age
• Patient who has already signed a consent to management

Exclusion Criteria

• Patient who expressed opposition to participating in the study

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Study of the evolution of pregnancies in the first trimester following MAR management during a COVD-19 pandemic period	12th week of Amenorrhea

Trial Locations

Locations (1)

Service Clinico biologique d'Assistance Médicale à La Procréation; 🇫🇷 Strasbourg, France